Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $454,639 - $476,665
-2,929 Reduced 5.77%
47,801 $7.56 Million
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $46.6 Million - $50.8 Million
-319,932 Reduced 86.31%
50,730 $7.95 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $13.6 Million - $15.2 Million
-87,000 Reduced 19.01%
370,662 $57.7 Million
Q2 2023

Dec 13, 2023

BUY
$154.35 - $166.11 $8.3 Million - $8.94 Million
53,797 Added 13.32%
457,662 $75.8 Million
Q2 2023

Aug 14, 2023

BUY
$154.35 - $166.11 $8.3 Million - $8.94 Million
53,797 Added 13.32%
457,662 $75.8 Million
Q1 2023

Dec 13, 2023

BUY
$151.05 - $180.26 $5.02 Million - $5.99 Million
33,203 Added 8.96%
403,865 $62.6 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $6.45 Million - $7.69 Million
42,679 Added 11.82%
403,865 $62.6 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $5.83 Million - $6.54 Million
36,382 Added 11.2%
361,186 $63.8 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $5.52 Million - $6.14 Million
34,229 Added 11.78%
324,804 $53.1 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $1.75 Million - $1.93 Million
-10,400 Reduced 3.46%
290,575 $51.6 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $1.01 Million - $1.15 Million
6,400 Added 2.17%
300,975 $53.3 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $73.8 Million - $81.9 Million
-473,523 Reduced 61.65%
294,575 $50.4 Million
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $68.6 Million - $76.3 Million
-424,925 Reduced 35.62%
768,098 $124 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $31.7 Million - $34 Million
198,500 Added 19.96%
1,193,023 $197 Million
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $13.9 Million - $15.5 Million
-90,633 Reduced 8.35%
994,523 $163 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $149 Million - $171 Million
1,085,156 New
1,085,156 $171 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Polar Capital Holdings PLC Portfolio

Follow Polar Capital Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.